Oritavancin Nitroso Impurity 1

Oritavancin Nitroso Impurity 1
Catalog No. KMO035022
CAS No. NA
Formula C86H96Cl3N11O27
FW 1822.1
Unit Price Stock
100 mg Enquire Enquire
Purity >95%
Storage Store at 2-8 deg. C for long term storage
Shipping Product is stable to be Shipped at Room Temperature
Download MSDS

Related Products

4-Chloro-4'-Biphenyl-Epi-Vancosamine

4-Chloro-4'-Biphenyl-Epi-Vancosamine

CAS No. : NA

CAT No. : KMO035001

Formula : C20H24ClNO3

FW : 361.9

View Details
Chloroorienticin A

Chloroorienticin A

CAS No. : 118395-73-6

CAT No. : KMO035002

Formula : C73H88Cl2N10O26

FW : 1592.5

View Details
Chloroorienticin B

Chloroorienticin B

CAS No. : 118373-81-2

CAT No. : KMO035003

Formula : C66H75Cl2N9O24

FW : 1449.3

View Details
Chloroorienticin C

Chloroorienticin C

CAS No. : 118373-82-3

CAT No. : KMO035004

Formula : C60H65Cl2N9O19

FW : 1287.1

View Details
Dechloroeremomycin

Dechloroeremomycin

CAS No. : 112848-47-2

CAT No. : KMO035005

Formula : C73H90N10O26

FW : 1523.6

View Details
Des methyl oritavancin

Des methyl oritavancin

CAS No. : NA

CAT No. : KMO035006

Formula : C85H95Cl3N10O26

FW : 1779.1

View Details
Des N-Methyl Leucine

Des N-Methyl Leucine

CAS No. : 216382-10-4

CAT No. : KMO035007

Formula : C79H84Cl3N9O25

FW : 1665.9

View Details
Eremomycin

Eremomycin

CAS No. : 110865-90-2

CAT No. : KMO035008

Formula : C73H89ClN10O26

FW : 1558.0

View Details
Oritavancin

Oritavancin

CAS No. : 171099-57-3

CAT No. : KMO035009

Formula : C86H97Cl3N10O26

FW : 1793.1

View Details
Oritavancin Alkylated Factor A

Oritavancin Alkylated Factor A

CAS No. : 354123-19-6

CAT No. : KMO035010

Formula : C86H98Cl2N10O26

FW : 1758.7

View Details
Oritavancin Alkylated Factor C

Oritavancin Alkylated Factor C

CAS No. : NA

CAT No. : KMO035011

Formula : C86H99ClN10O26

FW : 1724.2

View Details
Oritavancin Alkylated Factor D

Oritavancin Alkylated Factor D

CAS No. : NA

CAT No. : KMO035012

Formula : C88H99Cl3N10O28

FW : 1851.2

View Details
Oritavancin CR

Oritavancin CR

CAS No. : 808758-23-8

CAT No. : KMO035013

Formula : C86H97Cl3N10O26

FW : 1793.1

View Details
Oritavancin F

Oritavancin F

CAS No. : NA

CAT No. : KMO035014

Formula : C86H96Cl3N9O27

FW : 1794.1

View Details
Oritavancin Impurity 1

Oritavancin Impurity 1

CAS No. : NA

CAT No. : KMO035015

Formula : C86H97Cl3N10O26

FW : 1793.1

View Details
Oritavancin Impurity 2

Oritavancin Impurity 2

CAS No. : NA

CAT No. : KMO035016

Formula : C86H97Cl3N10O26

FW : 1793.1

View Details
Oritavancin Impurity 3

Oritavancin Impurity 3

CAS No. : 179530-90-6

CAT No. : KMO035017

Formula : C99H106Cl4N10O26

FW : 1993.8

View Details
Oritavancin Impurity 4

Oritavancin Impurity 4

CAS No. : 179530-89-3

CAT No. : KMO035018

Formula : C99H106Cl4N10O26

FW : 1993.8

View Details
Oritavancin Impurity 5

Oritavancin Impurity 5

CAS No. : NA

CAT No. : KMO035019

Formula : C99H106Cl4N10O26

FW : 1993.8

View Details
Oritavancin Impurity 6

Oritavancin Impurity 6

CAS No. : 179530-91-7

CAT No. : KMO035020

Formula : C112H115Cl5N10O26

FW : 2194.4

View Details
Oritavancin methyl ester

Oritavancin methyl ester

CAS No. : 2280037-19-4

CAT No. : KMO035021

Formula : C87H99Cl3N10O26

FW : 1807.1

View Details
Oritavancin Nucleus Factor D

Oritavancin Nucleus Factor D

CAS No. : NA

CAT No. : KMO035024

Formula : C75H90Cl2N10O28

FW : 1650.5

View Details
Oritavancin Related Substances E/G

Oritavancin Related Substances E/G

CAS No. : NA

CAT No. : KMO035025

Formula : C86H96Cl3N9O27

FW : 1794.1

View Details
Oritavancin Nitroso Impurity 2

Oritavancin Nitroso Impurity 2

CAS No. : NA

CAT No. : KMO035023

Formula : C86H96Cl3N11O27

FW : 1822.1

View Details

About Us

K. M. Pharma Solution Pvt. Ltd., India (CIN: U72100GJ2023PTC141278), is a leading, innovation-driven company accredited by FDCA, GMP-GLP, ISO 9001:2015, and NABL (ISO/IEC 17025 & ISO 17034). Specializing in the design, synthesis, and characterization of pharmaceutical impurity standards and reference materials, we offer an extensive portfolio including nitrosamine impurities, pharmacopeial and non-pharmacopeial impurities, drug metabolites, glucuronides, process degradants, excipient-related impurities, unknown impurity isolation & structural elucidation, and stable isotope-labeled compounds.

As an integrated Contract Research, Development & Manufacturing Organization (CRDMO), we provide end-to-end scientific services — from early-stage discovery through to commercial supply — with a strong focus on quality, compliance, and customer satisfaction.

Contact Us

  • Unit No.101, Shivam Industrial park,
    Sarkhej-bavala NH=8A, At-Moraiya, Changodar,
    Ahmedabad (Gujarat), India - 382213
  • contact@kmpharma.in
  • +91 9898822121

© 2025 K.M.Pharma. All Rights Reserved